Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: A retrospective study

Diseases of the Esophagus

Volumn 19, Issue 1, 2006, Pages 15-19

  Yamashita, H ^a   Nakagawa, K ^a   Tago, M ^a   Igaki, H ^a   Nakamura, N ^a   Shiraishi, K ^a   Sasano, N ^a   Ohtomo, K ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

5 FU; Cisplatin; Esophageal cancer; Nedaplatin; Radiation therapy

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BOLUS INJECTION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; ESOPHAGITIS; ESOPHAGUS CANCER; FEMALE; HUMAN; JAPAN; LEUKOPENIA; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; NAUSEA AND VOMITING; NEPHROTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; SEPTIC SHOCK; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645960413     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00531.x     Document Type: Article

References (18)

1. Siewert J, Fink U, Beckurts K et al. Surgery of squamous cell carcinoma of the esophagus. Ann Oncol 1994; 5: 1-7.
2. Herskovic A, Martz K, al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
3. Smith T J, Ryan L M, Douglass H O et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42: 269-76.
4. Jeremic B, Shibamoto Y, Acimovic L et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: A phase II study. Int J Radiat Oncol Biol Phys 1998; 40: 1061-6.
5. Hsu C H, Yeh K H, Lui L T et al. Concurrent chemoradiotherapy for locally advanced esophageal cancer - a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil. Anticancer Res 1999; 19: 4463-7.
6. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and/ or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
7. Murakami M, Kuroda Y, Nakajima T et al. Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 1999; 45: 277-84.
8. Sasaki Y, Amano T, Morita M et al. Phase I study and pharmacological analysis of cis-diammine (glycolato) platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion. Cancer Res 1991; 51: 1472-7.
9. Uchida N, Takeda Y, Hojo K et al. Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model. Eur J Cancer 1998; 34: 1796-801.
10. Yoshioka T, Gamoh M, Shineha R et al. A new combination chemotherapy with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for advanced esophageal cancers. Intern Med 1999; 38: 844-8.
11. Miller A B, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
12. Cox J D, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
13. Yamanaka H, Motohiro T, Michiura T et al. Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer. Jpn J Thorac Cardiovasc Surg 1998; 46: 943-8.
14. Nemoto K, Matsushita H, Ogawa Y et al. Radiation Therapy Combined With Cis-Diammine-Glycolatoplatinum (Nedaplatin) and 5-Fluorouracil for Untreated and Recurrent Esophageal Cancer. Am J Clin Oncol 2003; 26: 46-9.
15. Muro K, Shirao K, Shimada Y et al. A phase I-II study of Nedaplatin and 5-fluorouracil in patients with advanced esophageal cancer. Proc Am Soc Clin Oncol 1999; 18: 991.
16. Muro K. A phase II study of Nedaplatin and 5-fluorouracil in metastatic squamous cell carcioma of the esophagus: The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905). Jpn J Cancer Clin 2004; 50: 269-75.
17. Minsky B D, Pajak T F, Ginaberg R J et al. INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
18. Cooper J S, Guo M D, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999; 281: 1623-7.